|
|
|
Insider
Information: |
Hurvitz Eli |
Relationship: |
Director |
City: |
Carmiel, Israel |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
511,236 |
|
Indirect Shares
|
4,898,683 |
|
|
Direct
Value |
$1,319,891 |
|
|
Indirect Value
|
$1,296,192 |
|
|
Total
Shares |
5,409,919 |
|
|
Total
Value |
$2,616,082 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Protalix Biotherapeutics |
PLX |
Director |
2009-11-12 |
455,240 |
2009-11-12 |
4,898,683 |
Premium* |
|
Vishay Intertechnology Inc |
VSH |
Director |
2011-01-03 |
55,996 |
2008-05-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VSH |
Vishay Intertechnology In... |
Director |
|
2011-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
55,996 |
0 |
- |
|
VSH |
Vishay Intertechnology In... |
Director |
|
2010-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
45,996 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2009-11-12 |
4 |
S |
$10.00 |
$13,909,670 |
I/I |
(1,371,967) |
1,514,480 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2009-11-12 |
4 |
OE |
$0.00 |
$3,385 |
I/I |
3,384,502 |
4,898,982 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2009-11-12 |
4 |
D |
$11.33 |
$3,388 |
I/I |
(299) |
4,898,683 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2009-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,443,443) |
455,240 |
0 |
- |
|
VSH |
Vishay Intertechnology In... |
Director |
|
2008-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
35,996 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2006-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,886,447 |
2,886,447 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|